4/24/2017 | DD | Violin Memory second amended plan of reorganization effective Friday
|
4/18/2017 | DD | Violin Memory second amended plan of reorganization confirmed by court
|
4/17/2017 | DD | Violin Memory records wider $1.53 million operating loss for March
|
4/13/2017 | DD | Violin Memory amended plan accepted by majority of voting creditors
|
3/22/2017 | DD | Violin Memory records $726,972 operating loss for February
|
3/14/2017 | DD | Violin Memory files second amended plan; confirmation hearing April 18
|
3/6/2017 | DD | Violin Memory disclosure statement and DIP financing OK’d by court
|
2/23/2017 | DD | Violin Memory records $604,955 operating loss for month ended Jan. 31
|
2/16/2017 | DD | Violin Memory files plan of reorganization based on sponsor agreement
|
2/16/2017 | DD | Violin Memory granted interim access to $3.1 million of DIP financing
|
2/6/2017 | DD | Violin Memory seeks approval of sponsorship agreement, DIP facility
|
2/2/2017 | DD | Violin Memory records $1.16 million operating loss for Dec. 14-Dec. 31
|
1/27/2017 | DD | Violin Memory: Winning bid for assets calls for plan sponsorship deal
|
1/6/2017 | DD | Violin Memory bid procedures approved; auction scheduled for Jan. 23
|
12/28/2016 | DD | Violin Memory three-member unsecured creditors committee appointed
|
12/15/2016 | CVDD | Violin Memory files Chapter 11 bankruptcy to find buyer for assets
|
11/28/2016 | CVDD | Violin Memory’s 4.25% convertibles to be putable after stock delisted
|
4/13/2016 | DD | Market Commentary: Distressed energy debt rallies on output cut hopes, oil price boost; healthcare converts underperform
|
4/12/2016 | CV | Market Commentary: Horizon Pharma drops; Clovis in focus; Anacor, Depomed slip; Chesapeake extends gains
|
10/6/2014 | CV | Violin Memory greenshoe exercised, ups convertible sale to $120 million
|
9/19/2014 | PP | Market Commentary: New Violin Memory quiet on debut; Concur surges outright, slips on hedge; Tibco eases
|
9/19/2014 | CV | Market Commentary: New Violin Memory quiet on debut; Concur surges outright, slips on hedge; Tibco eases
|
9/19/2014 | CV | Market Commentary: Morning Commentary: New Violin quiet on debut; Concur ‘comes in’ on hedge on buyout news
|
9/19/2014 | CV | New Issue: Violin Memory prices upsized $105 million five-year convertibles to yield 4.25%, up 27.5%
|
9/18/2014 | CV | Market Commentary: PDL BioPharma drops after auditor news; Gilead remains weaker; secondary softness persists
|
9/18/2014 | CV | Market Commentary: Morning Commentary: PDL BioPharma 4% convertibles drop; two small, new deals in the market
|
9/18/2014 | CV | Violin Memory to price $95 million of five-year convertibles to yield 4%-4.5%, up 25%-30%
|